CbdMD Reports Mixed Q2 Results

CbdMD Inc YCBD reported second-quarter results Thursday that arrived higher than expected and included a record sales figure. 

What Happened

For the second quarter, the CBD oil maker reported net sales on a GAAP basis of $5.7 million, up by 84 percent on the year, beating the consensus estimate by $2.47 million. 

CbdMD posted a net loss of $31.8 million, of which 97 percent represented a change in the value of contingent liability related to the acquisition of the cbdMD brand.

cbdMD's net loss of 9 cents per share was wider than the expected loss of 5 cents per share. 

The company said it registered 70 percent of net sales through its e-commerce sales platform. 

cbdMD finished the quarter with $12.3 millon in working capital. 

Why It's Important

On May 1, cbdMD became the first CBD company to trade on the NYSE American and the first CBD company to trade on a major U.S. exchange.

The company has signed a number of partnerships with athletes, including professional golfer Bubba Watson and former UFC Light Heavyweight Champion Quinton "Rampage" Jackson.

Price Action

CbdMD shares were down 2.52 percent at $6.19 at the time of publication Thursday. 

Related Links:

How This CBD Company Is Tackling A New Market: 'It's Important To Be First'

Springtime Is Warming Up For Regulating CBD

Bubba Watson, left, Caryn Dunayer, Marty Sumichrast, Todd Justice and Quinton "Rampage" Jackson. Photo courtesy of cbdMD.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsMarketsCBDcbdMD
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.